PotBotics Takes Aim at the Vaporizer Market with RYAH

Vaporizers have become ubiquitous across many parts of the country. You can’t walk more than ten minutes in Los Angeles or Denver without coming across someone vaping on the sidewalk. Not surprisingly, the market for vaporizers is projected to exceed $60 billion by 2025, creating a significant opportunity for investors. Tobacco and recreational cannabis have become hot areas of investment, but medical cannabis is ripe for innovation.

PotBotics Inc., a leading data aggregation and technology company in the global medical cannabis market, launched an innovative new vaporizer in December designed specifically for medical cannabis users. Investors may want to take a closer look at vaporizer trends and the company’s innovative approach as it looks to go public over the near-term.

CFN Media recently sat down with PotBotics Co-founder and CEO David Goldstein to demonstrate the company’s innovative new vaporizer product, RYAH

Growing Market for Vaporizers

The global e-cigarette and vaporizer market is projected to grow at a 20.8 percent compound annual growth rate to $61.4 billion by 2025, according to Research and Markets, which notes that the cannabis industry is a major source of growth in the industry. While the recreational cannabis industry represents a large potential market, vaporizers could be most impactful in the medical cannabis market where patients need alternatives to smoking.

Most medical users still smoke cannabis as their primary delivery method. After all, igniting buds is the simplest way to reach temperatures needed to release cannabinoids. The problem is that smoke inhalation delivers damaging carcinogens and other materials through the bronchial tree and into the lungs. Long-term exposure to these chemicals in the lungs can lead to a range of medical conditions, including COPD and lung cancer. Ignition methods can also be very inconsistent, which makes it hard to achieve predictable results.

Vaporizers are an increasingly popular alternative with fewer, if any, negative side-effects. Instead of burning buds and producing smoke, vaporizers dehydrate buds in a way that releases cannabinoids without ever catching fire. No carcinogens or other harmful chemicals ever enter the lungs, but users still benefit from the greater bioavailability of smoking versus other consumption methods that are subject to metabolism by the liver.

Please Click Here to see an Investor Presentation

RYAH Ensures Predictable Results

Medical cannabis enjoys widespread support among doctors. In fact, a 2013 survey found that more than three-quarters of doctors would approve the use of medical marijuana. The problem is that there are few standardized delivery methods that guarantee dosages and measure the effects of cannabinoids in individual patients. In other words, it’s much harder for a doctor to tell a patient to go to a dispensary than for them to write a prescription.

PotBotics, a leading data aggregation and technology company in the global medical cannabis market, aims to change those dynamics with its new dose-measuring vaporizer. RYAH is the first vaporizer that lets users track and control a wide range of variables—including inhalation amount and temperatures—to ensure consistent and predictable results when used with its medical-grade oil or dry herb capsules.

RYAH Vaporizer and Companion App – Source: PotBotics Inc.

The company’s companion app lets consumers easily set their dosing parameters and track what medicine works best for them. In addition, the data can be shared with physicians and compiled into meaningful data sets to analyze efficacy. The company’s long-term goal is to advance the understanding of cannabinoids to a point where they can predict patient outcomes by measuring both individual experiences and medical literature.

“Consumers have picked up the micro-dosing trends, but unknowingly, have also accepted a lack of transparency for their medical regimen,” says PotBotics CEO David Goldstein. “RYAH is here to break that mold. We are very pleased to bring state-of-the-art technology to complement our existing suite of products in order to further understand and predict patient outcomes.”

Looking Ahead

PotBotics Inc. has developed an innovative vaporizer that cuts through the oversaturated market to help medical cannabis patients improve their experience. With the market projected to reach $60 billion by 2025, investors may want to take a closer look at the company as it rolls out RYAH, advances its data-driven products, and looks to go public over the near-term.

For more information, visit the company’s website at www.potbotics.com.

Please Click Here to see an Investor Presentation

Disclaimer  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.